Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

91 structures for P15880

Entry ID Method Resolution Chain Position Source
4UG0 EM - SC 1-293 PDB
4V6X EM 500 A AC 1-293 PDB
5A2Q EM 390 A C 1-293 PDB
5AJ0 EM 350 A BC 1-293 PDB
5FLX EM 390 A C 1-293 PDB
5LKS EM 360 A SC 1-293 PDB
5OA3 EM 430 A C 1-293 PDB
5T2C EM 360 A AJ 1-293 PDB
5VYC X-ray 600 A C1/C2/C3/C4/C5/C6 1-293 PDB
6G18 EM 360 A C 1-293 PDB
6G4S EM 400 A C 1-293 PDB
6G51 EM 410 A C 1-293 PDB
6G53 EM 450 A C 1-293 PDB
6G5H EM 360 A C 1-293 PDB
6G5I EM 350 A C 1-293 PDB
6IP5 EM 390 A 3G 1-293 PDB
6IP6 EM 450 A 3G 1-293 PDB
6IP8 EM 390 A 3G 1-293 PDB
6OLE EM 310 A SC 59-278 PDB
6OLF EM 390 A SC 59-278 PDB
6OLG EM 340 A BC 57-278 PDB
6OLI EM 350 A SC 59-278 PDB
6OLZ EM 390 A BC 57-278 PDB
6OM0 EM 310 A SC 59-278 PDB
6OM7 EM 370 A SC 59-278 PDB
6QZP EM 290 A SC 59-280 PDB
6XA1 EM 280 A SC 59-278 PDB
6Y0G EM 320 A SC 1-293 PDB
6Y2L EM 300 A SC 1-293 PDB
6Y57 EM 350 A SC 1-293 PDB
6YBD EM 330 A L 1-293 PDB
6YBW EM 310 A L 1-293 PDB
6Z6L EM 300 A SC 1-293 PDB
6Z6M EM 310 A SC 1-293 PDB
6Z6N EM 290 A SC 1-293 PDB
6ZLW EM 260 A D 1-293 PDB
6ZM7 EM 270 A SC 1-293 PDB
6ZME EM 300 A SC 1-293 PDB
6ZMI EM 260 A SC 1-293 PDB
6ZMO EM 310 A SC 1-293 PDB
6ZMT EM 300 A D 1-293 PDB
6ZMW EM 370 A L 1-293 PDB
6ZN5 EM 320 A D 59-276 PDB
6ZOJ EM 280 A C 1-293 PDB
6ZOK EM 280 A C 1-293 PDB
6ZON EM 300 A d 1-293 PDB
6ZP4 EM 290 A d 1-293 PDB
6ZUO EM 310 A C 1-293 PDB
6ZV6 EM 290 A C 1-293 PDB
6ZVH EM 290 A C 59-280 PDB
6ZVJ EM 380 A d 60-275 PDB
6ZXD EM 320 A C 1-293 PDB
6ZXE EM 300 A C 1-293 PDB
6ZXF EM 370 A C 1-293 PDB
6ZXG EM 260 A C 1-293 PDB
6ZXH EM 270 A C 1-293 PDB
7A09 EM 350 A d 1-293 PDB
7JQB EM 270 A D 1-293 PDB
7JQC EM 330 A D 1-293 PDB
7K5I EM 290 A C 1-293 PDB
7QP6 EM 470 A L 1-293 PDB
7QP7 EM 370 A L 1-293 PDB
7QVP EM 300 A RC/SC 1-293 PDB
7R4X EM 215 A C 1-293 PDB
7TQL EM 340 A D 59-276 PDB
7WTV EM 350 A C 1-293 PDB
7WTW EM 320 A C 1-293 PDB
7WTX EM 310 A C 1-293 PDB
7WTZ EM 300 A C 1-293 PDB
7WU0 EM 330 A C 1-293 PDB
7XNX EM 270 A SC 1-293 PDB
7XNY EM 250 A SC 1-293 PDB
8G5Y EM 229 A SC 1-293 PDB
8G5Z EM 264 A SC 59-280 PDB
8G60 EM 254 A SC 1-293 PDB
8G61 EM 294 A SC 1-293 PDB
8G6J EM 280 A SC 1-293 PDB
8GLP EM 167 A SC 1-293 PDB
8IFD EM 259 A 3G 1-293 PDB
8IFE EM 257 A 3G 1-293 PDB
8JDJ EM 250 A z 1-293 PDB
8JDK EM 226 A z 1-293 PDB
8JDL EM 242 A z 1-293 PDB
8JDM EM 267 A z 1-293 PDB
8OZ0 EM 350 A O 1-293 PDB
8PPK EM 298 A C 1-293 PDB
8PPL EM 265 A AC 1-293 PDB
8T4S EM 260 A C 1-293 PDB
8Y0W EM 340 A SC 1-293 PDB
8Y0X EM 330 A SC 1-293 PDB
AF-P15880-F1 Predicted AlphaFoldDB

222 variants for P15880

Variant ID(s) Position Change Description Diseaes Association Provenance
CA394272852
rs1567318687
2 A>G No ClinGen
Ensembl
CA7823903
rs770974083
6 G>A No ClinGen
ExAC
gnomAD
TCGA novel 6 G>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs762654490
CA7823901
7 A>E No ClinGen
ExAC
TOPMed
gnomAD
CA7823902
rs747260490
7 A>T No ClinGen
ExAC
gnomAD
rs762654490
CA394272790
7 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA7823900
rs772256506
8 A>T No ClinGen
ExAC
rs1223985092
CA394272784
8 A>V No ClinGen
gnomAD
rs989713704
CA394272771
9 G>A No ClinGen
TOPMed
gnomAD
rs989713704
CA276754449
9 G>E No ClinGen
TOPMed
gnomAD
CA276754462
rs12397561
CA7823898
9 G>R No ClinGen
ExAC
gnomAD
rs989713704
CA394272768
9 G>V No ClinGen
TOPMed
gnomAD
CA394272774
rs12397561
9 G>W No ClinGen
ExAC
gnomAD
rs1304830476
CA394272759
10 G>A No ClinGen
gnomAD
CA276754444
rs958307866
10 G>R No ClinGen
Ensembl
rs780574188
CA7823894
11 P>L No ClinGen
ExAC
gnomAD
CA394272749
rs199558614
11 P>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA7823896
rs199558614
11 P>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA276754404
CA7823892
rs751281003
12 G>R No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 12 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7823893
rs751281003
12 G>W No ClinGen
ExAC
TOPMed
gnomAD
CA394272716
rs1158100558
13 G>D No ClinGen
gnomAD
rs752493327
CA7823889
14 P>L No ClinGen
ExAC
gnomAD
rs1197854287
CA394272699
15 G>S No ClinGen
gnomAD
CA7823888
rs7204258
16 G>A No ClinGen
ExAC
TOPMed
gnomAD
CA276754394
rs7204258
16 G>V No ClinGen
ExAC
TOPMed
gnomAD
rs753857917 16 G>missing Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs759395923
CA7823887
17 P>L No ClinGen
ExAC
gnomAD
rs532422534
CA7823886
18 G>A No ClinGen
1000Genomes
ExAC
gnomAD
CA7823883
CA7823882
rs760788760
19 M>I No ClinGen
ExAC
gnomAD
rs1462933757
CA394272617
20 G>E No ClinGen
gnomAD
rs1281652651
CA394272620
20 G>R No ClinGen
gnomAD
rs773241417
CA276754367
21 N>I No ClinGen
ExAC
TOPMed
gnomAD
rs773241417
CA7823881
21 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs772350714
CA7823880
22 R>S No ClinGen
ExAC
gnomAD
CA394272581
rs11543072
23 G>D No ClinGen
gnomAD
rs1344704493
CA394272583
23 G>R No ClinGen
TOPMed
gnomAD
rs1344704493
CA394272585
23 G>S No ClinGen
TOPMed
gnomAD
CA276754365
rs11543072
23 G>V No ClinGen
gnomAD
CA7823879
rs748360461
24 G>S No ClinGen
ExAC
gnomAD
rs11538721
CA394272551
27 G>E No ClinGen
gnomAD
rs11538721
CA276754359
27 G>V No ClinGen
gnomAD
CA394272549
rs1597039617
28 G>S No ClinGen
Ensembl
CA276754356
rs11543094
28 G>V No ClinGen
Ensembl
CA394272502
rs1174971944
32 G>S No ClinGen
TOPMed
gnomAD
rs1365798435
CA394272471
35 G>S No ClinGen
TOPMed
TCGA novel 36 R>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7823876
rs749792856
38 R>H No ClinGen
ExAC
gnomAD
rs780562414
CA7823875
40 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA394272351
rs1328635891
41 G>V No ClinGen
TOPMed
rs756667522
CA7823872
42 R>W No ClinGen
ExAC
TOPMed
gnomAD
rs746558635
CA7823871
45 G>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 48 R>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7823864
rs752326265
49 G>A No ClinGen
ExAC
gnomAD
rs1322740881
CA394272219
50 A>P No ClinGen
gnomAD
CA7823863
rs764971592
50 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA394272201
rs1359566012
52 G>R No ClinGen
gnomAD
rs1334790430
CA394272163
55 A>D No ClinGen
gnomAD
TCGA novel 55 A>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1334790430
CA394272159
55 A>V No ClinGen
gnomAD
TCGA novel 56 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs753552285
CA7823860
56 E>Q No ClinGen
ExAC
CA276754132
rs1029985840
CA394272087
60 W>C No ClinGen
TOPMed
rs139767914
CA7823820
CA7823821
61 M>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1222079959
CA394272081
61 M>L No ClinGen
TOPMed
gnomAD
rs1222079959
CA394272082
61 M>V No ClinGen
TOPMed
gnomAD
CA394272071
rs866276648
62 P>A No ClinGen
TOPMed
CA276754127
rs866276648
62 P>S No ClinGen
TOPMed
CA394272052
rs1597039341
63 V>G No ClinGen
Ensembl
rs1364094385
CA394272032
65 K>M No ClinGen
gnomAD
rs763240039
CA7823815
67 G>D No ClinGen
ExAC
gnomAD
CA7823814
rs368176620
68 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA394271988
rs1195590985
69 L>F No ClinGen
gnomAD
rs1411219537
CA394271968
71 K>M No ClinGen
gnomAD
rs1428215411
CA394271965
CA394271963
71 K>N No ClinGen
TOPMed
rs771532107
CA7823810
72 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA276754093
rs773232994
73 M>I No ClinGen
Ensembl
CA394271909
rs1266498173
75 I>N No ClinGen
TOPMed
gnomAD
rs1208958881
CA394271901
76 K>R No ClinGen
TOPMed
gnomAD
rs1567318373
CA394271892
77 S>A No ClinGen
Ensembl
CA7823809
rs761069719
77 S>F No ClinGen
ExAC
TOPMed
gnomAD
CA394271888
rs761069719
77 S>Y No ClinGen
ExAC
TOPMed
gnomAD
CA394271883
rs746887497
78 L>V No ClinGen
TOPMed
CA7823807
rs767988974
79 E>A No ClinGen
ExAC
gnomAD
rs374258583
CA394271851
80 E>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1015985571
CA276754082
80 E>G No ClinGen
Ensembl
CA7823804
rs769415014
81 I>M No ClinGen
ExAC
gnomAD
rs745704132
CA276754069
82 Y>C No ClinGen
ExAC
gnomAD
CA7823803
rs745704132
82 Y>F No ClinGen
ExAC
gnomAD
rs1201265849
CA394271819
83 L>V No ClinGen
TOPMed
rs370163380
CA7823799
85 S>F No ClinGen
ESP
ExAC
gnomAD
rs752801500
CA394271734
87 P>A No ClinGen
ExAC
TOPMed
gnomAD
rs752801500
CA7823795
87 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA7823747
rs757776418
98 L>R No ClinGen
ExAC
gnomAD
rs751997551
CA7823746
100 A>V No ClinGen
ExAC
gnomAD
rs1207931958
CA394270304
101 S>F No ClinGen
gnomAD
CA276753389
rs990662419
103 K>E No ClinGen
TOPMed
rs764747805
CA7823745
103 K>N No ClinGen
ExAC
gnomAD
rs1297107737
CA394270261
105 E>D No ClinGen
gnomAD
CA7823744
rs759094044
105 E>K No ClinGen
ExAC
gnomAD
rs1340327640
CA394270262
105 E>V No ClinGen
gnomAD
CA7823742
rs766012844
110 M>T No ClinGen
ExAC
gnomAD
CA276753386
rs1035105096
113 Q>* No ClinGen
TOPMed
rs760357971
CA7823741
117 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA394270131
rs1368370305
117 R>H No ClinGen
gnomAD
rs867556469
CA276753383
119 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs1597037811
CA394270067
121 R>C No ClinGen
Ensembl
CA394270062
rs1415317836
121 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA394270052
rs1179553053
122 T>I No ClinGen
gnomAD
rs924906278
CA276753283
126 A>S No ClinGen
Ensembl
rs11543107
CA276753282
126 A>V No ClinGen
Ensembl
rs1429351694
CA394269825
129 A>D No ClinGen
TOPMed
gnomAD
rs1429351694
CA394269822
129 A>V No ClinGen
TOPMed
gnomAD
rs1165095549
CA394269808
131 G>R No ClinGen
gnomAD
rs766466013
CA7823650
133 Y>* No ClinGen
ExAC
gnomAD
rs11543098
CA7823649
134 N>D No ClinGen
ExAC
TOPMed
gnomAD
CA276753252
rs11543098
134 N>H No ClinGen
ExAC
TOPMed
gnomAD
rs201628829
CA7823648
134 N>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs767849793
CA7823647
135 G>A No ClinGen
ExAC
gnomAD
CA7823644
rs769075167
137 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs1353635350
CA394269732
138 G>S No ClinGen
gnomAD
CA394269658
rs1388559512
144 S>F No ClinGen
Ensembl
rs927854415
CA276753238
145 K>R No ClinGen
TOPMed
CA394269615
rs1597037291
147 V>G No ClinGen
Ensembl
rs778796528
CA7823635
154 A>S No ClinGen
ExAC
gnomAD
rs753605404
CA7823633
156 I>V No ClinGen
ExAC
gnomAD
CA394269451
rs1246988614
157 L>P No ClinGen
gnomAD
rs750576891
CA7823630
159 K>M No ClinGen
ExAC
gnomAD
rs767441011
CA7823629
159 K>N No ClinGen
ExAC
gnomAD
CA394269374
rs1466214610
162 I>V No ClinGen
gnomAD
CA394269350
rs1227600615
163 V>F No ClinGen
TOPMed
gnomAD
CA394269355
rs1227600615
163 V>I No ClinGen
TOPMed
gnomAD
CA394269338
rs1238607990
164 P>A No ClinGen
TOPMed
CA394269329
rs1345449379
164 P>H No ClinGen
gnomAD
CA394269316
rs1231356093
165 V>L No ClinGen
gnomAD
CA394269303
rs1330678784
166 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1567317156
CA394269298
166 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs1321337545
CA394269293
167 R>G No ClinGen
gnomAD
CA394269268
rs1387106171
168 G>A No ClinGen
TOPMed
CA7823624
rs543253316
172 N>D No ClinGen
1000Genomes
ExAC
gnomAD
rs11543118
CA276753208
173 K>N No ClinGen
Ensembl
CA394269133
rs770479865
174 I>M No ClinGen
ExAC
TOPMed
gnomAD
rs759902795
CA7823622
175 G>S No ClinGen
ExAC
TOPMed
gnomAD
rs1427710783
CA394269076
177 P>T No ClinGen
gnomAD
rs1171113495
CA394269052
178 H>R No ClinGen
gnomAD
rs11543074
CA276753200
178 H>Y No ClinGen
Ensembl
CA394268997
rs1376665253
181 P>S No ClinGen
gnomAD
CA394268962
rs1188695244
183 K>R No ClinGen
TOPMed
gnomAD
rs1264827706
CA394268839
184 V>M No ClinGen
TOPMed
CA7823596
rs748885661
187 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs775271566
CA7823595
187 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA276753137
rs11543075
188 C>R No ClinGen
Ensembl
COSM3420817
rs76844476
CA276753134
194 R>C large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA7823592
rs76844476
194 R>S No ClinGen
ExAC
gnomAD
CA394268603
rs1251329879
197 P>L No ClinGen
gnomAD
rs566623400
CA7823590
198 A>S No ClinGen
1000Genomes
ExAC
gnomAD
rs566623400
CA394268601
198 A>T No ClinGen
1000Genomes
ExAC
gnomAD
CA276753121
rs17856937
202 T>I No ClinGen
Ensembl
TCGA novel 205 V>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs533119033
CA7823584
208 P>H No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 210 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7823582
rs761232903
211 K>R No ClinGen
ExAC
gnomAD
CA7823580
rs763531958
213 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs775074747
CA7823578
215 M>L No ClinGen
ExAC
TOPMed
gnomAD
rs769466457
CA7823577
215 M>T No ClinGen
ExAC
gnomAD
rs1003181864
CA276753046
218 G>S No ClinGen
TOPMed
TCGA novel 219 I>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA394268228
rs1412555185
219 I>V No ClinGen
gnomAD
rs145914766
CA7823574
220 D>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1398145021
CA394268211
220 D>N No ClinGen
TOPMed
CA7823573
rs746875524
222 C>S No ClinGen
ExAC
gnomAD
CA276753019
rs929142323
224 T>I No ClinGen
TOPMed
rs1217398563
CA394268117
225 S>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA7823570
rs748212461
227 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA7823571
rs369095700
227 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs779039730
CA7823569
228 G>S No ClinGen
ExAC
TOPMed
gnomAD
rs754211411
CA7823567
230 T>A No ClinGen
ExAC
gnomAD
CA394267994
rs1219448992
230 T>S No ClinGen
gnomAD
rs780411000
CA7823566
231 A>V No ClinGen
ExAC
gnomAD
rs750894365
CA7823564
237 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA7823478
rs748534788
243 A>G No ClinGen
ExAC
gnomAD
rs11543069
CA276752636
245 S>F No ClinGen
Ensembl
TCGA novel 245 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 247 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA276752629
rs11539480
247 T>N No ClinGen
Ensembl
CA394266192
rs1452021980
251 L>V No ClinGen
gnomAD
CA276751374
rs11543112
252 T>N No ClinGen
Ensembl
rs1466154917
CA394266158
253 P>H No ClinGen
gnomAD
rs374773804
CA7823474
254 D>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA394266145
rs1259319580
254 D>G No ClinGen
TOPMed
rs1192932025
CA394266151
254 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1346027608
CA394266056
259 T>S No ClinGen
gnomAD
rs751433066
CA7823472
260 V>I No ClinGen
ExAC
gnomAD
CA394266031
rs777377021
261 F>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA276751302
rs1051537930
264 S>P No ClinGen
TOPMed
CA394265960
rs1437914020
266 Y>F No ClinGen
gnomAD
CA394265946
rs1361313392
267 Q>H No ClinGen
TOPMed
CA394265891
rs1597036480
271 D>A No ClinGen
Ensembl
CA276751279
rs3211583
272 H>P No ClinGen
Ensembl
CA7823466
rs753906824
274 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1393972551
CA394265826
276 T>A No ClinGen
gnomAD
rs760750249
CA7823464
276 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs1393972551
CA394265827
276 T>P No ClinGen
gnomAD
rs772283358
CA7823462
278 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA394265795
rs772283358
278 T>P No ClinGen
ExAC
TOPMed
gnomAD
rs762435329
CA7823461
279 R>K No ClinGen
ExAC
gnomAD
CA276751181
rs992070916
280 V>A No ClinGen
Ensembl
rs140783691
CA7823458
280 V>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs140783691
CA394265766
280 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs140783691
CA7823459
280 V>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs142405634
CA7823456
282 V>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1230644525
CA394265730
283 Q>* No ClinGen
gnomAD
CA7823454
rs367578393
284 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs746578617
CA7823455
284 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA394265697
rs758173961
285 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs758173961
CA7823453
285 T>S No ClinGen
ExAC
TOPMed
gnomAD
CA7823452
rs752453825
286 Q>* No ClinGen
ExAC
gnomAD
CA394265673
rs1168272425
287 A>V No ClinGen
Ensembl
rs1056415734
CA276751160
288 P>L No ClinGen
TOPMed
CA394265667
rs1180756035
288 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
TCGA novel 289 A>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs778885599
CA7823450
289 A>V No ClinGen
ExAC
gnomAD

No associated diseases with P15880

3 regional properties for P15880

Type Name Position InterPro Accession
domain Ribosomal protein S5, C-terminal 186 - 258 IPR005324
domain Ribosomal protein S5, N-terminal 102 - 166 IPR013810
conserved_site Ribosomal protein S5, N-terminal, conserved site 119 - 151 IPR018192

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Nucleus, nucleolus
  • Probably localized to nucleolus and cytoplasm in complex with ZNF277
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

9 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
cytosolic ribosome A ribosome located in the cytosol.
cytosolic small ribosomal subunit The small subunit of a ribosome located in the cytosol.
extracellular exosome A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
focal adhesion A cell-substrate junction that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. In insects focal adhesion has also been referred to as hemi-adherens junction (HAJ).
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

6 GO annotations of molecular function

Name Definition
cadherin binding Binding to cadherin, a type I membrane protein involved in cell adhesion.
enzyme binding Binding to an enzyme, a protein with catalytic activity.
fibroblast growth factor binding Binding to a fibroblast growth factor.
mRNA binding Binding to messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns.
RNA binding Binding to an RNA molecule or a portion thereof.
structural constituent of ribosome The action of a molecule that contributes to the structural integrity of the ribosome.

3 GO annotations of biological process

Name Definition
cytoplasmic translation The chemical reactions and pathways resulting in the formation of a protein in the cytoplasm. This is a ribosome-mediated process in which the information in messenger RNA (mRNA) is used to specify the sequence of amino acids in the protein.
positive regulation of ubiquitin-protein transferase activity Any process that activates, maintains or increases the rate of ubiquitin transferase activity.
translation The cellular metabolic process in which a protein is formed, using the sequence of a mature mRNA or circRNA molecule to specify the sequence of amino acids in a polypeptide chain. Translation is mediated by the ribosome, and begins with the formation of a ternary complex between aminoacylated initiator methionine tRNA, GTP, and initiation factor 2, which subsequently associates with the small subunit of the ribosome and an mRNA or circRNA. Translation ends with the release of a polypeptide chain from the ribosome.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O18789 RPS2 40S ribosomal protein S2 Bos taurus (Bovine) PR
P25444 Rps2 40S ribosomal protein S2 Mus musculus (Mouse) PR
P27952 Rps2 40S ribosomal protein S2 Rattus norvegicus (Rat) PR
P93014 PCMP-H6 30S ribosomal protein S5, chloroplastic Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MADDAGAAGG PGGPGGPGMG NRGGFRGGFG SGIRGRGRGR GRGRGRGRGA RGGKAEDKEW
70 80 90 100 110 120
MPVTKLGRLV KDMKIKSLEE IYLFSLPIKE SEIIDFFLGA SLKDEVLKIM PVQKQTRAGQ
130 140 150 160 170 180
RTRFKAFVAI GDYNGHVGLG VKCSKEVATA IRGAIILAKL SIVPVRRGYW GNKIGKPHTV
190 200 210 220 230 240
PCKVTGRCGS VLVRLIPAPR GTGIVSAPVP KKLLMMAGID DCYTSARGCT ATLGNFAKAT
250 260 270 280 290
FDAISKTYSY LTPDLWKETV FTKSPYQEFT DHLVKTHTRV SVQRTQAPAV ATT